Table 1.
Clinicopathologic features | n = 213 |
---|---|
Sex | |
Male | 126 (59.2%) |
Female | 87 (40.8%) |
Age (years)* | |
Mean (SD) | 72 (11.3) |
BMI* | |
Mean (SD) | 23.2 (4.1) |
Comorbidities | |
Cardiac disease | 37 (17.3%) |
Lung disease | 23 (10.8%) |
Diabetes mellitus | 46 (21.6%) |
Location of tumor | |
C | 17 |
A | 42 |
T | 20 |
D | 8 |
S | 46 |
R | 80 |
pT stage | |
Tis-T2 | 93 (43.7%) |
T3-T4 | 120 (56.3%) |
pN stage | |
Positive | 60 (28.2%) |
Negative | 153 (61.8%) |
pStage | |
0 | 10 |
I | 73 |
II | 63 |
III | 49 |
IV | 18 |
Surgical procedure | |
Laparoscopy | 187 (87.8%) |
Open | 26 (12.2%) |
Operative time (min)* | |
Mean (SD) | 265.9 (111.9) |
Intraoperative bleeding (ml)* | |
Mean (SD) | 117.5 (332.1) |
Postoperative complications | |
All | 96 (45.1%) |
Surgical site infection | 50 (23.5%) |
Anastomotic leakage | 17 (8.0%) |
Remote infection | 12 (5.6%) |
POI | 21 (9.9%) |
CDC grade | |
I | 21 (9.9%) |
II | 53 (24.9) |
IIIa | 20 (9.4%) |
IIIb | 6 (2.8%) |
IVa | 1 (0.5%) |
Continuous parameters are presented as mean (SD)*, and categorical parameters are presented as n (%), C cecum cancer, A ascending colon cancer, T transverse colon cancer, D descending colon cancer, S sigmoid colon cancer, R rectum cancer, Tis carcinoma in situ, POI postoperative ileus, CDC Clavien-Dindo classification, SD standard deviation